The monoclonal antibody 2D5 neutralized vaccinia virus by preventing penetration of the virus and reacting with VP23-29K. The conformation of the VP23-29K was maintained by a disulfide bond(s), and the 2D5mAb reacted stronger with the nonreduced 23-kDa form than with the reduced 29-kDa form. We selected several escape mutants. Sequences of the A17L genes, which were thought to encode the VP23-29K, did not show cognate mutation. Genomic DNA of a 2D5mAb-resistant mutant (M4) was cleaved with HindIII, and all the fragments were introduced into parental IHD-J strain vaccinia virus by transfection. Only the L fragment produced a 2D5mAb-resistant virus. Dissection of the L fragment and subsequent transfection revealed that the L1R gene induced the 2D5mAb-resistant virus. The 2D5mAb-resistant mutants showed a consensus G to A conversion at nucleotide 101 of their LIRs which would replace asparatic acid 35 with asparagine. Ishibashi-111 strain mousepox virus spontaneously resistant to 2D5mAb also had the same sequence at this region. Moreover, the VP23-29K was myristoylated as predicted by the L1R gene. The coding gene of the VP23-29K was L1R. ᭧ 1996 Academic Press, Inc.
Vaccinia virus infects cells by means of membrane
virus did not cause cell fusion, while the M4 mutant induced cell fusion at the late stage of infection. fusion and induces syncytia at the late stage of infection. The inhibition of the membrane fusion phenomena by a
The 2D5mAb-resistant mutants were tested using three anti-VP23-29K mAbs ( Table 1 ). The M1, M2, and monoclonal antibody (2D5mAb) suggests that its target antigen has an important role in the processes. The M4 mutant viruses were resistant to the 2D5mAb and G7H5mAb, whereas the 8C2mAb neutralized them with 2D5mAb reacts with nonreduced 23-kDa protein and with reduced 29-kDa protein of the virus, and we termed this the same efficiency as the parental IHD-J strain virus. All three mAbs neutralized the CPR-C1 strain of cowpox and protein VP23-29K (1, 2) . N-terminal amino acid sequence Copenhagen strain of monkeypox viruses, but the Ishianalysis indicates its coding gene to be A17L. However, bashi-111 strain of mousepox virus was resistant to the unlike the nonreduced 23-kDa form, the reduced 29-kDa 2D5/G7H5mAb and sensitive to the 8C2mAb. The VP23-protein reacted weakly with the 2D5mAb, and direct N-29K had two distinct neutralizing epitopes. One was reacterminal amino acid sequencing of the 29-kDa protein tive to 2D5mAb/G7H5mAb, and the other was defined did not produce signals. Recently the 2D5mAb was reby 8C2mAb. The 8C2-reactive epitope was conserved ported to react with L1R encoded protein that behaved among a wide range of orthopoxviruses, whereas the like VP23-29K (3).
2D5/G7H5mAb-reactive epitope varied between the M1/ To further characterize the VP23-29K, we selected mu-M2/M4/mousepox and vaccinia/cowpox/monkeypox vitants that were resistant to neutralization by the 2D5mAb. rus groups. Vero cells infected with the IHD-J strain of vaccinia virus Structural proteins of the three 2D5mAb-resistant muwere incubated in the presence of a mutagen (MNNG) to tants were separated by SDS-PAGE and then immuinduce point mutations into the progeny virus (4). Mutant noblotted against 2D5mAb and 8C2mAb ( Fig. 1) . Two viruses were treated with trypsin to remove extracellular vaccinia viruses (IHD-J and WR strains) and vaccinia muenveloped virus (EEV), because the EEV was resistant tants (D1 and vRB10), the CPR-C1 strain of cowpox, the to neutralization (5) . The activated viruses were selected Ishibashi-111 strain of mousepox, and the Copenhagen by the 2D5mAb. After three repeated selective passages, strain of monkeypox virus were examined in parallel. All the titer of the progeny virus was no longer reduced by the virus samples were adjusted to 20 mg/lane. Profiles exposure to the 2D5mAb. Three clones (M1, M2, and M4) of the viral proteins were revealed by silver staining the were isolated and plaque purified. Cells infected with the gel ( the nonreduced 23-kDa protein was a highly antigenic component common to all the tested viruses.
Sensitivity of Viruses to Neutralizing Antibodies
When the samples were stained with the 2D5mAb Note. Purified IMV samples were diluted with DMEM to give a titer of 2000 PFU/ml. Monoclonal antibodies and anti-vaccinia serum (1, 5, proteins. The results indicated that the 2D5mAb-resistant of the M2/M4/mousepox viruses.
A DNA fragment containing the promoter and the entire ORF sequence of A17L was cloned from genomic due to a change of the protein configuration by reduction.
DNA of the IHD-J and the mutant viruses and then seThe relationships are shown in the two-dimensional elecquenced. The A17L genes of the M1 and M2 mutants trophoresis profiles presented in the literature (1, 6, 7) .
and parental IHD-J strain virus were identical to that of Overall, the viruses presented similar profiles except for the Copenhagen strain of vaccinia virus (8), except for G a lack of VP32K in the D1 mutant virus (A-1) and slight to A conversions at the nucleotides 120 and 360. The differences in the cowpox and mousepox viruses. The A17L of the M4 mutant contained a single point mutation silver-stained profiles indicated that VP23-29K was a mi-(C to T) at the nucleotide 226 which would substitute nor component of the viruses, but the profiles stained with polyclonal anti-vaccinia mouse serum indicated that serine for proline 67. To examine whether the corre- 
FIG. 2.
Nucleotide sequences of A17L and L1R. Genomic DNA of CPR.C1 strain cowpox, Ishibashi-111 strain mousepox virus, and recHH1 was applied to PCR. Primers are indicated at both ends by boldface letters. The PCR products were cloned into pBluescriptII (KS / and SK / ) and then sequenced. The sequences were lined up with those of the IHD-J strain vaccinia virus, as well as the M1, M2, and M4 mutants of which the entire genes were sequenced. sponding protein of mousepox virus varies from the with the other DNA fragments did not produce 2D5mAb-resistant virus. VP23-29K at amino acid 67 or nearby, the genetic region encoding amino acid residues 37-116 was amplified by
The HindIII L fragment of the M4 mutant DNA was cloned into a plasmid and cleaved with XbaI. The left PCR and sequenced (Fig. 2) . The A17L equivalents of mousepox and cowpox viruses showed several different half contained part of G9R, L1R, and a portion of L2R (nucleotide sequence of 79244-80965). The fragment nucleotides, but the amino acid residues were not affected. Mousepox and cowpox viruses had amino acid was further cleaved with BamHI and the left end of HindIII/BamHI was digested for about 150 nucleotides. sequences identical to that of the IHD-J strain virus concerning this region. The A17L genes of M1/M2/ Transfection with this fragment (L1R of the M4 mutant) produced 2D5mAb-resistant virus. mousepox viruses were not involved in the antigenic variation found in their VP23-29K.
The L1Rs of IHD-J, M1, and M4 viruses were sequenced. The M1 and M4 viruses contained the identical The resistance to 2D5mAb was considered to be encoded by a gene other than A17L. Genomic DNA of the mutation of G to A at nucleotide 101 of the L1R ORF (80256). There was no other difference in the L1Rs. The M4 mutant virus was digested with HindIII, and the generated A to P fragments were isolated by agarose gel mutation would substitute asparagine for aspartic acid 35. Part of the L1R ORF (80150-80378), corresponding electrophoresis. Each of the DNA fragments was transfected into CV-1 cells infected with IHD-J strain virus to the coding region of the amino-terminal 74 amino acid residues, was amplified from genomic DNAs of the M2 (9), and the progeny was screened with the 2D5mAb. Resistance to the 2D5mAb was found in the progeny mutant, mousepox, and cowpox viruses (Fig. 2) . The M2 mutant and mousepox virus contained the same variation virus grown in cells transfected with the L fragment. The virus (recHH1) was plaque purified. Cultures transfected as that of M1/M4 mutants, whereas the amino acid se-was purified. The IMV was dissociated in nonreducing lysis buffer and then precipitated with the 8C2mAb or 2D5mAb. The immune complex was collected on protein A-agarose beads and dissolved for electrophoresis (Fig.  3 ). When the immunoprecipitate by the 2D5mAb was dissociated with nonreducing buffer, the 2D5mAb reacted with the 23-and 21-kDa proteins (Fig. 3B) . The 8C2mAb reacted with its 23-kDa band, and distribution of tritiumlabeled myristoylated protein coincided with the 23-kDa band. On the other hand, the 8C2mAb precipitated only the 23-kDa myristoylated protein, and it reacted with the 2D5mAb. Neither the 21-nor the 19-kDa protein was detectable in the 8C2mAb precipitate. The myristoylated protein in the precipitates migrated as a 29-kDa protein after reduction (Fig. 3A) , and the reduction diminished indicated that the gene encoding the VP23-29K was L1R, ated with 1% SDS (1 ml) and passed through a column to remove the SDS. The 2D5mAb or 8C2mAb (1/500 diluted, 500 ml) was mixed as reported by Wolffe et al. (3) , and that the VP23-29K
with an equal volume of the lysed sample. As the 8C2mAb did not corresponded to the myristoylated protein M25 reported adsorb to protein A, anti-mouse IgG (1/500 diluted, 30 ml, Bio-Rad) by Franke et al. (10) . The 2D5mAb recognized epitopes was added to the mixture. Immune complexes were collected using on the nonreduced 21-and 19-kDa proteins and VP23- parallel. Viral proteins were stained with polyclonal anti-vaccinia mouse serum. Lane 2: Precipitate with 2D5mAb was immunostained
